OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,405,002 | -7.7% | 437,652 | -32.5% | 1.05% | +7.9% |
| Q2 2023 | $5,854,628 | +69.4% | 648,353 | -34.9% | 0.98% | +47.0% |
| Q1 2023 | $3,455,804 | -2.2% | 995,909 | -30.9% | 0.66% | -2.9% |
| Q4 2022 | $3,532,422 | +44.9% | 1,441,805 | +63.3% | 0.68% | +42.5% |
| Q3 2022 | $2,437,000 | -73.9% | 883,056 | +161.0% | 0.48% | -38.1% |
| Q3 2021 | $9,326,000 | -32.0% | 338,381 | -30.9% | 0.78% | -30.0% |
| Q2 2021 | $13,711,000 | +3103.5% | 490,020 | +3698.6% | 1.11% | +3365.6% |
| Q1 2021 | $428,000 | – | 12,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |